Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


A new lawsuit involving Stanford and Sequoia Capital highlights fights to come over cell-free DNA testing

External Link - Source: TechCrunch

Publicly traded transplant diagnostics company called CareDx, along with Stanford University, sued another publicly traded genetic testing company, Natera, for patent infringement.

Much appears to be at stake, and it all centers on cell-free DNA testing, a type of technology that has already been at the crux of numerous lawsuits and looks poised to play center stage again in future corporate battles.

This entry was posted in Genetics. Bookmark the permalink.